Cargando…
A protocol for feasibility of plasma based GeneXpert platform and Dried Blood Spot (DBS) based Abbott platform for HIV-1 viral load testing among the people living with HIV attending ART centers in India
BACKGROUND: HIV-1 Viral load (VL) measures efficiency of the antiretroviral therapy (ART) after treatment initiation and helps to diagnose virological failures at an early stage. Current VL assays require sophisticated laboratory facilities. As well as there are other challenges pertaining to insuff...
Autores principales: | Kamble, Suchit, Shidhaye, Pallavi, Mukherjee, Anupam, Tak, Madhuri, Bembalkar, Shilpa, Aggarwal, Sumit, Deb, Arpita, Kapoor, Neha, Verma, Vinita, Das, Chinmoyee, Kulkarni, Smita, Ghate, Manisha, Godbole, Sheela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194862/ https://www.ncbi.nlm.nih.gov/pubmed/37200292 http://dx.doi.org/10.1371/journal.pone.0285942 |
Ejemplares similares
-
Missed opportunities for integrated testing of HIV and tuberculosis on the GeneXpert platform in Lesotho
por: Gwaza, Gamuchirai P., et al.
Publicado: (2023) -
Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe
por: Ndlovu, Zibusiso, et al.
Publicado: (2018) -
Loss to follow-up of HIV-exposed infants for confirmatory HIV test under Early Infant Diagnosis program in India: analysis of national-level data from reference laboratories
por: Gawde, Nilesh, et al.
Publicado: (2022) -
Effectiveness of GeneXpert(®) in the diagnosis of tuberculosis in people living with HIV/AIDS
por: de Faria, Mariana Gaspar Botelho Funari, et al.
Publicado: (2021) -
Equivalence of the GeneXpert System and GeneXpert Omni System for tuberculosis and rifampicin resistance detection
por: Georghiou, Sophia B., et al.
Publicado: (2021)